Status:
COMPLETED
Evaluation of Anti-oxidant, Anti-aging and Wellbeing Effects of a Novel Nutraceutical Formulation (HealthSpan)
Lead Sponsor:
National Hellenic Research Foundation
Collaborating Sponsors:
Theracell Advanced Biotechnology
Conditions:
Aging
Well Aging
Eligibility:
All Genders
29-85 years
Phase:
NA
Brief Summary
The study was designed as a randomized, placebo-controlled trial with follow-up at 3 months. The study is in accordance with the Declaration of Helsinki and was approved by the Institutional Bioethica...
Detailed Description
The study was designed as a randomized, placebo-controlled trial with follow-up at 3 months. The study is in accordance with the Declaration of Helsinki and was approved by the Institutional Bioethica...
Eligibility Criteria
Inclusion
- residence in the Athens metropolitan area
- age 29-85
Exclusion
- diagnosed cancer, subjects that were under chemotherapy, therapy with biological factors and radiotherapy
- use of nutritional supplements during the clinical trial period
- diagnosed autoimmune diseases or other chronic diseases
- subjects that had lived less than 50% of their life in the country that is their current residence.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT05202652
Start Date
September 1 2019
End Date
August 31 2021
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Chemical Biology of National Hellenic Research Foundation
Athens, Attica, Greece, 11635